{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:47:24Z","timestamp":1790754444590,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013465","name":"AFM-Telethon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002738","name":"Assistance Publique - Hopitaux de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009820","name":"Assistance publique-H\u00f4pitaux de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009820","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.nmd.2021.06.010","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T05:07:37Z","timestamp":1624770457000},"page":"1124-1135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study"],"prefix":"10.1016","volume":"31","author":[{"given":"Savine","family":"Vicart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Franques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Bouhour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle","family":"Magot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"P\u00e9r\u00e9on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Nadaj-Pakleza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Behin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00ebl","family":"Zahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"H\u00e9zode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Payan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucette","family":"Lacomblez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2021.06.010_bib0001","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1212\/WNL.0b013e318260cbe6","article-title":"Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1)","volume":"79","author":"Heatwole","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.06.010_bib0002","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1212\/WNL.0000000000002225","article-title":"Patient-reported impact of symptoms in myotonic dystrophy type 2 (PRISM-2)","volume":"85","author":"Heatwole","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.06.010_bib0003","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00415-009-5049-y","article-title":"Health status in non-dystrophic myotonias: close relation with pain and fatigue","volume":"256","author":"Trip","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2021.06.010_bib0004","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1212\/01.CON.0000440661.49298.c8","article-title":"Muscle channelopathies: the nondystrophic myotonias and periodic paralyses","volume":"19","author":"Statland","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.nmd.2021.06.010_bib0005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/mus.880100704","article-title":"AAEE minimonograph #27: differential diagnosis of myotonic syndromes","volume":"10","author":"Streib","year":"1987","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.06.010_bib0006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/brain\/awp294","article-title":"The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment","volume":"133","author":"Matthews","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.06.010_bib0007","first-page":"665","article-title":"[Myotonia with muscular weakness corrected by exercise. the therapeutic effect of mexiletine]","volume":"139","author":"Pouget","year":"1983","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.nmd.2021.06.010_bib0008","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neucli.2017.01.003","article-title":"Neuromuscular excitability changes produced by sustained voluntary contraction and response to mexiletine in myotonia congenita","volume":"47","author":"Ginanneschi","year":"2017","journal-title":"Neurophysiol Clin"},{"key":"10.1016\/j.nmd.2021.06.010_bib0009","first-page":"130","article-title":"Autosomal dominant myotonia congenita in a Taiwanese family and beneficial response to mexiletine","volume":"12","author":"Kuo","year":"2003","journal-title":"Acta Neurol Taiwan"},{"key":"10.1016\/j.nmd.2021.06.010_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00042752-199704000-00012","article-title":"Unusual causes of stiffness in two hockey players","volume":"7","author":"Burnham","year":"1997","journal-title":"Clin J Sport Med"},{"key":"10.1016\/j.nmd.2021.06.010_bib0011","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ncpneuro0239","article-title":"Myotonia congenita\u2013a cause of muscle weakness and stiffness","volume":"2","author":"Chrestian","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.nmd.2021.06.010_bib0012","first-page":"413","article-title":"Electrophysiological evaluation of congenital myotonia","volume":"25","author":"Rossi","year":"1985","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"10.1016\/j.nmd.2021.06.010_bib0013","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0035-3787(07)74181-4","article-title":"[Eulenburg's paramyotonia congenita]","volume":"163","author":"Sallansonnet-Froment","year":"2007","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.nmd.2021.06.010_bib0014","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/(SICI)1097-4598(199908)22:8<1157::AID-MUS26>3.0.CO;2-H","article-title":"Electro-oculographic findings in an unusual case of paramyotonia congenita","volume":"22","author":"Colazza","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.06.010_bib0015","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/mus.880170710","article-title":"Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy","volume":"17","author":"Jackson","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.06.010_bib0016","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archneur.1994.00540230033009","article-title":"A third type of muscle sodium channel disease","volume":"51","author":"Ricker","year":"1994","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2021.06.010_bib0017","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/jama.2012.12607","article-title":"Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial","volume":"308","author":"Statland","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.nmd.2021.06.010_bib0018","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jamaneurol.2015.2338","article-title":"Long-term safety and efficacy of mexiletine for patients with skeletal muscle Channelopathies","volume":"72","author":"Suetterlin","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nmd.2021.06.010_bib0019","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1001\/jama.2018.18020","article-title":"Effect of Mexiletine on muscle stiffness in patients with nondystrophic myotonia evaluated using aggregated N-of-1 Trials","volume":"320","author":"Stunnenberg","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.nmd.2021.06.010_bib0020","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Mexiletine AP-HP 200mg, g\u00e9lule. Avis de la Commission de la Transparence (19 janvier 2011). Available at: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2011-02\/mexiletine_-_ct-9407.pdf (last accessed May 19, 2020)."},{"key":"10.1016\/j.nmd.2021.06.010_bib0021","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/01.wnl.0000257819.47628.41","article-title":"Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL)","volume":"68","author":"Vincent","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.06.010_bib0022","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/mus.24337","article-title":"The individualized neuromuscular quality of life questionnaire: cultural translation and psychometric validation for the Dutch population","volume":"51","author":"Seesing","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.06.010_bib0023","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.20241","article-title":"Electromyography guides toward subgroups of mutations in muscle channelopathies","volume":"56","author":"Fournier","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2021.06.010_bib0024","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ana.20905","article-title":"Cold extends electromyography distinction between ion channel mutations causing myotonia","volume":"60","author":"Fournier","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2021.06.010_bib0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.clinph.2014.06.008","article-title":"Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita","volume":"126","author":"Lo Monaco","year":"2015","journal-title":"Clin Neurophysiol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621001644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621001644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:11:59Z","timestamp":1760775119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896621001644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0960896621001644"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2021.06.010","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2021.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}